Five other numbers that show the unit’s growth:
1. IngenioRx had an operating gain of $407 million in the three months ended March 31, up 16.6 percent from the same period a year before.
2. The PBM reflects 18.3 percent of Anthem’s first-quarter operating revenue.
3. IngenioRx’s operating margin was 6.9 percent in the first quarter of this year, up from 6.7 percent in the first quarter of 2020.
More articles on payers:
Biden administration revokes billions in Texas Medicaid funding
Stanford Health Care sues Anthem, alleges breach of implied contract
Avalere founder to head up JPMorgan healthcare innovation
